Tecogen (TGEN) Misses Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts TGEN Hot Sheet
Price: $3.10 --0%
EPS Growth %: +14.3%
Financial Fact:
Total operating expenses: 3.44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +14.3%
Financial Fact:
Total operating expenses: 3.44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Tecogen (OTC: TGEN) reported Q4 EPS of ($0.13), $0.09 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.32 million versus the consensus estimate of $7.27 million.
For earnings history and earnings-related data on Tecogen (TGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Akari Therapeutics to present ADC platform at five September conferences
- Truist on Armstrong World Industries (AWI): 'Buy on Current Market Dip'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
